The Patent Finder
AB

Aura Biosciences, Inc.

First filing 2011
OverviewNotableFeesChangesFamiliesPatent listSources & methods

4 patents currently held

9 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
4 more records may belong here and await a decision; they are not counted.

The next term ends in Feb 2033. from the record

Of the 9 now held by other companies, 6 name United States of America as Represented by the Secretary Department of Health and Human Services as their current owner, and 3 more name another party. Each row says which.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Feb 2033
Next term end
1
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents fee due within 90 days all others Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 1 of the currently held patents qualifies as notable.

Formerly held, still cited

Notable
The most cited patent in this portfolio, cited by 98 later US patents, top 5% of utility patents granted in 2017 in our data. Protection runs to 2030.
Ends Apr 2030 · High confidence
Also notable
Cited by 30 later US patents, top 10% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2034.
Ends Sep 2034 · High confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Nov 28, 2026
    The maintenance fee for Virion-Derived Nanospheres for Selective Delivery of Therapeutic and Diagnostic Agents to Cancer Cells (US 10,300,150) comes due Nov 28, 2026. Unpaid by May 28, 2027, it lapses early.
  • 1 fee due Sep 24, 2027
    The maintenance fee for Virion-Derived Nanospheres for Selective Delivery of Therapeutic and Diagnostic Agents to Cancer Cells (US 10,596,275) comes due Sep 24, 2027. Unpaid by Mar 24, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

What they patent

Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.

Showing 1 to 4 of 4

PatentTitleStatusExpiresConfidence
US 9,700,639Virion-Derived Nanospheres for Selective Delivery of Therapeutic and Diagnostic Agents to Cancer Cells
In force
 · High confidence
In forceHigh confidence
US 9,855,347Virion-Derived Nanospheres for Selective Delivery of Therapeutic and Diagnostic Agents to Cancer Cells
In force
 · Medium confidence
In forceMedium confidence
US 10,300,150Virion-Derived Nanospheres for Selective Delivery of Therapeutic and Diagnostic Agents to Cancer Cells
In force
 · Medium confidence
In forceMedium confidence
US 10,596,275Virion-Derived Nanospheres for Selective Delivery of Therapeutic and Diagnostic Agents to Cancer Cells
In force
 · Medium confidence
In forceMedium confidence
Also on record, not counted in the 4: 9 patents in force now held by others · 3 applications pending · 8 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
5 terminal disclaimers are on file with no resolved reference. No cap is applied and none is guessed
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited